IBDEI0BL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5484,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,5484,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,5485,0)
 ;;=788.41^^41^486^58
 ;;^UTILITY(U,$J,358.3,5485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5485,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,5485,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,5485,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,5486,0)
 ;;=788.31^^41^486^62
 ;;^UTILITY(U,$J,358.3,5486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5486,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,5486,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,5486,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,5487,0)
 ;;=788.20^^41^486^63
 ;;^UTILITY(U,$J,358.3,5487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5487,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,5487,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,5487,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,5488,0)
 ;;=112.2^^41^486^66
 ;;^UTILITY(U,$J,358.3,5488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5488,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,5488,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,5488,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,5489,0)
 ;;=600.01^^41^486^5
 ;;^UTILITY(U,$J,358.3,5489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5489,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,5489,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,5489,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,5490,0)
 ;;=600.10^^41^486^40
 ;;^UTILITY(U,$J,358.3,5490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5490,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,5490,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,5490,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,5491,0)
 ;;=585.9^^41^486^8
 ;;^UTILITY(U,$J,358.3,5491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5491,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,5491,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,5491,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,5492,0)
 ;;=788.64^^41^486^59
 ;;^UTILITY(U,$J,358.3,5492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5492,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,5492,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,5492,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,5493,0)
 ;;=788.65^^41^486^52
 ;;^UTILITY(U,$J,358.3,5493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5493,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,5493,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,5493,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,5494,0)
 ;;=600.00^^41^486^4
 ;;^UTILITY(U,$J,358.3,5494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5494,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,5494,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,5494,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,5495,0)
 ;;=599.70^^41^486^20
 ;;^UTILITY(U,$J,358.3,5495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5495,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,5495,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,5495,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,5496,0)
 ;;=599.71^^41^486^21
 ;;^UTILITY(U,$J,358.3,5496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5496,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,5496,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,5496,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,5497,0)
 ;;=599.72^^41^486^22
 ;;^UTILITY(U,$J,358.3,5497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5497,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,5497,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,5497,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,5498,0)
 ;;=596.89^^41^486^12
 ;;^UTILITY(U,$J,358.3,5498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5498,1,4,0)
 ;;=4^596.89
